Clinical Trial Update: A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This document notes the termination of a Phase 1/2 trial evaluating 5-azacitidine with bevacizumab in advanced renal cell carcinoma and that results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-06-14